Better Growth Buy: Eli Lilly vs. Viking Therapeutics
Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) have garnered considerable attention over the past year due to their solid clinical progress. However, these drugmakers have also lagged the market over the trailing-12-month period. That said, there are good reasons to expect both to bounce back and perform well over the long run.
But which is a better stock to invest in today? Let's find out.
Image source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Stock
€22.20
0.450%
Viking Therapeutics Inc is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 45 € there is potential for a 102.75% increase which would mean more than doubling the current price of 22.2 € for Viking Therapeutics Inc.
